- Home
- EXEL vs ALAB Comparison
EXEL vs ALAB Comparison
Compare EXEL & ALAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- ALAB
- Stock Information
- Founded
- EXEL 1994
- ALAB 2017
- Country
- EXEL United States
- ALAB United States
- Employees
- EXEL N/A
- ALAB N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- ALAB
- Sector
- EXEL Health Care
- ALAB
- Exchange
- EXEL Nasdaq
- ALAB NYSE
- Market Cap
- EXEL 9.8B
- ALAB 10.6B
- IPO Year
- EXEL 2000
- ALAB 2024
- Fundamental
- Price
- EXEL $43.04
- ALAB $90.10
- Analyst Decision
- EXEL Buy
- ALAB Strong Buy
- Analyst Count
- EXEL 18
- ALAB 15
- Target Price
- EXEL $38.76
- ALAB $97.50
- AVG Volume (30 Days)
- EXEL 3.9M
- ALAB 4.9M
- Earning Date
- EXEL 05-13-2025
- ALAB 05-06-2025
- Dividend Yield
- EXEL N/A
- ALAB N/A
- EPS Growth
- EXEL 237.58
- ALAB N/A
- EPS
- EXEL 2.20
- ALAB 0.26
- Revenue
- EXEL $2,298,922,000.00
- ALAB $490,474,000.00
- Revenue This Year
- EXEL $10.39
- ALAB $79.74
- Revenue Next Year
- EXEL $10.74
- ALAB $28.96
- P/E Ratio
- EXEL $19.53
- ALAB $361.44
- Revenue Growth
- EXEL 24.49
- ALAB 200.19
- 52 Week Low
- EXEL $20.40
- ALAB $36.22
- 52 Week High
- EXEL $48.85
- ALAB $147.39
- Technical
- Relative Strength Index (RSI)
- EXEL 59.93
- ALAB N/A
- Support Level
- EXEL $42.21
- ALAB N/A
- Resistance Level
- EXEL $43.75
- ALAB N/A
- Average True Range (ATR)
- EXEL 1.60
- ALAB 0.00
- MACD
- EXEL -0.09
- ALAB 0.00
- Stochastic Oscillator
- EXEL 53.96
- ALAB 0.00
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ALAB ASTERA LABS INC
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.